{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:14:54Z","timestamp":1794932094056,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurodegenerative diseases like Alzheimer\u2019s disease, Parkinson\u2019s disease and Huntington\u2019s disease manifest with the neuronal accumulation of toxic proteins. Since autophagy upregulation enhances the clearance of such proteins and ameliorates their toxicities in animal models, we and others have sought to re-position\/re-profile existing compounds used in humans to identify those that may induce autophagy in the brain. A key challenge with this approach is to assess if any hits identified can induce neuronal autophagy at concentrations that would be seen in humans taking the drug for its conventional indication. Here we report that felodipine, an L-type calcium channel blocker and anti-hypertensive drug, induces autophagy and clears diverse aggregate-prone, neurodegenerative disease-associated proteins. Felodipine can clear mutant \u03b1-synuclein in mouse brains at plasma concentrations similar to those that would be seen in humans taking the drug. This is associated with neuroprotection in mice, suggesting the promise of this compound for use in neurodegeneration.<\/jats:p>","DOI":"10.1038\/s41467-019-09494-2","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T10:08:13Z","timestamp":1555582093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing"],"prefix":"10.1038","volume":"10","author":[{"given":"Farah H.","family":"Siddiqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Stamatakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Karabiyik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-3376","authenticated-orcid":false,"given":"Rodrigo","family":"Ureshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ricketts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-1582","authenticated-orcid":false,"given":"Maria","family":"Jimenez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1426-6809","authenticated-orcid":false,"given":"Miguel Angel","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangxue","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micky D.","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Metzakopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo J. R.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-9137","authenticated-orcid":false,"given":"Andrew","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Karran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeleen","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Rubinsztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"9494_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/hmg\/ddi458","volume":"15","author":"Z Berger","year":"2006","unstructured":"Berger, Z. et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15, 433\u2013442 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"9494_CR2","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","volume":"11","author":"B Ravikumar","year":"2002","unstructured":"Ravikumar, B., Duden, R. & Rubinsztein, D. C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11, 1107\u20131117 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"9494_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595 (2004).","journal-title":"Nat. Genet."},{"key":"9494_CR4","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N. & Rubinsztein, D. C. Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009\u201325013 (2003).","journal-title":"J. Biol. Chem."},{"key":"9494_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies, F. M. et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93, 1015\u20131034 (2017).","journal-title":"Neuron"},{"key":"9494_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams, A. et al. Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295\u2013305 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"9494_CR7","volume-title":"Approved drug products with therapeutic equivalence evaluations","author":"FDA.","year":"1985","unstructured":"FDA. Approved drug products with therapeutic equivalence evaluations. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drugs and Biologics, Washington, [Rockville, Md.], 1985)."},{"key":"9494_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13821","volume":"7","author":"M Pavel","year":"2016","unstructured":"Pavel, M. et al. CCT complex restricts neuropathogenic protein aggregation via autophagy. Nat. Commun. 7, 13821 (2016).","journal-title":"Nat. Commun."},{"key":"9494_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/auto.4451","volume":"3","author":"S Kimura","year":"2007","unstructured":"Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452\u2013460 (2007).","journal-title":"Autophagy"},{"key":"9494_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.4161\/auto.20284","volume":"8","author":"C Zhou","year":"2012","unstructured":"Zhou, C. et al. Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells. Autophagy 8, 1215\u20131226 (2012).","journal-title":"Autophagy"},{"key":"9494_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5998","volume":"5","author":"K Moreau","year":"2014","unstructured":"Moreau, K. et al. PICALM modulates autophagy activity and tau accumulation. Nat. Commun. 5, 4998 (2014).","journal-title":"Nat. Commun."},{"key":"9494_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5414\/NPP30003","volume":"30","author":"GG Kovacs","year":"2011","unstructured":"Kovacs, G. G. et al. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. Clin. Neuropathol. 30, 3\u201310 (2011).","journal-title":"Clin. Neuropathol."},{"key":"9494_CR13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awx005","volume":"140","author":"A Lopez","year":"2017","unstructured":"Lopez, A. et al. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction. Brain 140, 1128\u20131146 (2017).","journal-title":"Brain"},{"key":"9494_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.15252\/embr.201541438","volume":"17","author":"S Maeda","year":"2016","unstructured":"Maeda, S. et al. Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice. EMBO Rep. 17, 530\u2013551 (2016).","journal-title":"EMBO Rep."},{"key":"9494_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling, G. et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet 8, 397\u2013407 (1999).","journal-title":"Hum. Mol. Genet"},{"key":"9494_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/cdd.2014.151","volume":"22","author":"FM Menzies","year":"2015","unstructured":"Menzies, F. M. et al. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death Differ. 22, 433\u2013444 (2015).","journal-title":"Cell Death Differ."},{"key":"9494_CR17","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1093\/hmg\/ddq093","volume":"19","author":"C Rose","year":"2010","unstructured":"Rose, C. et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington\u2019s disease. Hum. Mol. Genet 19, 2144\u20132153 (2010).","journal-title":"Hum. Mol. Genet"},{"key":"9494_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s003359900551","volume":"8","author":"DC Rogers","year":"1997","unstructured":"Rogers, D. C. et al. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 8, 711\u2013713 (1997).","journal-title":"Mamm. Genome"},{"key":"9494_CR19","unstructured":"Astrazeneca.\u00a0PLENDIL (felodipine)\u00a0https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/019834s025lbl.pdf (2012)."},{"key":"9494_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2125.1991.tb03852.x","volume":"31","author":"E Blychert","year":"1991","unstructured":"Blychert, E., Edgar, B., Elmfeldt, D. & Hedner, T. A population study of the pharmacokinetics of felodipine. Br. J. Clin. Pharmacol. 31, 15\u201324 (1991).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"9494_CR21","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee, M. K. et al. Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl Acad. Sci. USA 99, 8968\u20138973 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9494_CR22","first-page":"1008","volume":"23","author":"JH Lin","year":"1995","unstructured":"Lin, J. H. Species similarities and differences in pharmacokinetics. Drug Metab. Dispos. 23, 1008\u20131021 (1995).","journal-title":"Drug Metab. Dispos."},{"key":"9494_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40139-015-0086-y","volume":"3","author":"EW Uhl","year":"2015","unstructured":"Uhl, E. W. & Warner, N. J. Mouse models as predictors of human responses: evolutionary medicine. Curr. Pathobiol. Rep. 3, 219\u2013223 (2015).","journal-title":"Curr. Pathobiol. Rep."},{"key":"9494_CR24","doi-asserted-by":"publisher","first-page":"e98961","DOI":"10.1371\/journal.pone.0098961","volume":"9","author":"YC Lee","year":"2014","unstructured":"Lee, Y. C. et al. Antihypertensive agents and risk of Parkinson\u2019s disease: a nationwide cohort study. PLoS ONE 9, e98961 (2014).","journal-title":"PLoS ONE"},{"key":"9494_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nchembio.1790","volume":"11","author":"M Jimenez-Sanchez","year":"2015","unstructured":"Jimenez-Sanchez, M. et al. siRNA screen identifies QPCT as a druggable target for Huntington\u2019s disease. Nat. Chem. Biol. 11, 347\u2013354 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"9494_CR26","doi-asserted-by":"crossref","unstructured":"Son, S. M. et al. Leucine signals to mTORC1 via its metabolite acetyl-coenzyme A. Cell Metab.\u00a029, 192\u2013201 (2018).","DOI":"10.1016\/j.cmet.2018.08.013"},{"key":"9494_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546, 370\u2013375 (2017).","journal-title":"Nature"},{"key":"9494_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 480, 547\u2013551 (2011).","journal-title":"Nature"},{"key":"9494_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253\u2013310 (1995).","journal-title":"Dev. Dyn."},{"key":"9494_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nature11992","volume":"496","author":"RN Kettleborough","year":"2013","unstructured":"Kettleborough, R. N. et al. A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature 496, 494\u2013497 (2013).","journal-title":"Nature"},{"key":"9494_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nmeth1033","volume":"4","author":"EK Scott","year":"2007","unstructured":"Scott, E. K. et al. Targeting neural circuitry in zebrafish using GAL4 enhancer trapping. Nat. Methods 4, 323\u2013326 (2007).","journal-title":"Nat. Methods"},{"key":"9494_CR32","doi-asserted-by":"publisher","first-page":"16027","DOI":"10.1074\/jbc.M710606200","volume":"283","author":"AL Orr","year":"2008","unstructured":"Orr, A. L. et al. Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice. J. Biol. Chem. 283, 16027\u201316036 (2008).","journal-title":"J. Biol. Chem."},{"key":"9494_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476\u2013481 (2005).","journal-title":"Science"},{"key":"9494_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0076-6879(99)09045-X","volume":"309","author":"SW Davies","year":"1999","unstructured":"Davies, S. W. et al. Detection of polyglutamine aggregation in mouse models. Methods Enzymol. 309, 687\u2013701 (1999).","journal-title":"Methods Enzymol."},{"key":"9494_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin, J. H. et al. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson\u2019s disease. Cell 144, 689\u2013702 (2011).","journal-title":"Cell"},{"key":"9494_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/002215549904700601","volume":"47","author":"SA Schnell","year":"1999","unstructured":"Schnell, S. A., Staines, W. A. & Wessendorf, M. W. Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J. Histochem. Cytochem. 47, 719\u2013730 (1999).","journal-title":"J. Histochem. Cytochem."},{"key":"9494_CR37","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari, S. et al. Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration. J. Clin. Invest. 126, 2970\u20132988 (2016).","journal-title":"J. Clin. Invest."}],"updated-by":[{"DOI":"10.1038\/s41467-019-10536-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09494-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09494-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09494-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T22:39:21Z","timestamp":1671230361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09494-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9494"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09494-2","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-019-10536-y","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,18]]},"assertion":[{"value":"2 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.M.M. is employed by Eli Lilly and E.K. is employed by and holds stock in Abbvie. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1817"}}